参考文献/References:
[1]Schüle S,Rossel JB,Frey D,et al.Widely differing screening and treatment practice for osteoporosis in patients with inflammatory bowel diseases in the Swiss IBD cohort study[J].Medicine,2017,96(22):e6788. [2]Ewid M,Al Mutiri N,Al Omar K,et al.Updated bone mineral density status in Saudi patients with inflammatory bowel disease[J].World Journal of Gastroenterology,2020,26(35):5343-5353. [3]Rubio MG,Amo-Mensah K,Gray JM,et al.Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease[J].World Journal of Gastrointestinal Pathophysiology,2019,10(5):54-63. [4]Kraemer A,Bulgakova T,Schukina O,et al.Automated Fecal Biomarker Profiling- a Convenient Procedure to Support Diagnosis for Patients with Inflammatory Bowel Diseases[J].Clinical Laboratory,2020,66(7). [5]Locantore P,Del Gatto V,Gelli S,et al.The Interplay between Immune System and Microbiota in Osteoporosis[J].Mediators of Inflammation,2020(2020):3686749. [6]Mena Bares LM,Benítez Cantero JM,Iglesias Flores E,et al.Bile acid malabsorption in patients with chronic diarrhea and Crohn’s disease[J].Revista Espanola De Enfermedades Digestivas:Organo Oficial De La Sociedad Espanola de Patologia Digestiva,2019,111(1):40-45. [7]Rivera ED,Coffey JC,Walsh D,et al.The Mesentery,Systemic Inflammation,and Crohn’s Disease[J].Inflammatory Bowel Diseases,2019,25(2):226-234. [8]Hanafy AS,Monir MH,Abdel Malak H,et al.A Simple Noninvasive Score Predicts Disease Activity and Deep Remission in Ulcerative Colitis[J].Inflammatory Intestinal Diseases,2018,3(1):16-24. [9]Klimczak K,Lykowska-Szuber L,Eder P,et al.The diagnostic usefulness of fecal lactoferrin in the assessment of Crohn’s disease activity[J].European Journal of Internal Medicine,2015,26(8):623-627. [10]Karnsund S,Lo B,Bendtsen F,et al.Systematic review of the prevalence and development of osteoporosis or low bone mineral density and its risk factors in patients with inflammatory bowel disease[J].World Journal of Gastroenterology,2020,26(35):5362-5374. [11]Nishida A,Inoue R,Inatomi O,et al.Gut microbiota in the pathogenesis of inflammatory bowel disease[J].Clinical Journal of Gastroenterology,2018,11(1):1-10. [12]Sgambato D,Gimigliano F,Musis C de,et al.Bone alterations in inflammatory bowel diseases[J].World Journal of Clinical Cases,2019,7(15):1908-1925. [13]Kotze LM d S,Costa CT,Cavassani MF,et al.Alert for bone alterations and low serum concentrations of vitamin D in patients with intestinal inflammatory disease[J].Revista da Associacao Medica Brasileira(1992),2017,63(1):13-17. [14]Cantorna MT,Rogers CJ,Arora J.Aligning the Paradoxical Role of Vitamin D in Gastrointestinal Immunity[J].Trends in Endocrinology and Metabolism,2019,30(7):459-466. [15]Nygaard L,Skallerup A,Olesen SS,et al.Osteoporosis in patients with intestinal insufficiency and intestinal failure:Prevalence and clinical risk factors[J].Clinical Nutrition,2018,37(5):1654-1660.
相似文献/References:
[1]曾 翔,文 星,常一航,等.营养风险筛查和BMI在克罗恩病患者营养评估中的应用[J].医学信息,2019,32(08):133.[doi:10.3969/j.issn.1006-1959.2019.08.039]
ZENG Xiang,WEN Xing,CHANG Yi-hang,et al.Application of Nutritional Risk Screening and BMI in Nutritional Assessment of Patients with Crohn's Disease[J].Medical Information,2019,32(05):133.[doi:10.3969/j.issn.1006-1959.2019.08.039]
[2]王莹洁,戴迟兵.益生菌在炎症性肠病中的应用研究[J].医学信息,2020,33(22):42.[doi:10.3969/j.issn.1006-1959.2020.22.013]
WANG Ying-jie,DAI Chi-bing.Study on the Application of Probiotics in Inflammatory Bowel Disease[J].Medical Information,2020,33(05):42.[doi:10.3969/j.issn.1006-1959.2020.22.013]
[3]郑鑫辉,崔慧丽,邵 进,等.克罗恩病患者骨质疏松症的影响因素分析[J].医学信息,2021,34(08):68.[doi:10.3969/j.issn.1006-1959.2021.08.018]
ZHENG Xin-hui,CUI Hui-li,SHAO Jin,et al.Analysis of Influencing Factors of Osteoporosis in Patients with Crohn’s Disease[J].Medical Information,2021,34(05):68.[doi:10.3969/j.issn.1006-1959.2021.08.018]
[4]马靖琳,王 婷,肖红斌,等.基于公共数据库分析FOXM1在软组织肉瘤中的表达及临床预后意义[J].医学信息,2024,37(01):1.[doi:10.3969/j.issn.1006-1959.2024.01.001]
MA Jing-lin,WANG Ting,XIAO Hong-bin,et al.Expression and Prognostic Significance of FOXM1 Gene in Soft Tissue Sarcomas Based on the Public Database[J].Medical Information,2024,37(05):1.[doi:10.3969/j.issn.1006-1959.2024.01.001]
[5]黄晓东,黄 衔,梁靖华,等.基于m6A相关长链非编码RNA鉴定克罗恩病的潜在诊断生物标志物[J].医学信息,2024,37(01):10.[doi:10.3969/j.issn.1006-1959.2024.01.002]
HUANG Xiao-dong,HUANG Xian,LIANG Jing-hua,et al.Identification of Potential Diagnostic Biomarkers for Crohn’s Disease Based on m6A-related Long Non-coding RNAs[J].Medical Information,2024,37(05):10.[doi:10.3969/j.issn.1006-1959.2024.01.002]